Inactive Instrument
Quotes GENFIT Euronext Paris
Stocks
FR0004163111
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
||
| 14.27 EUR | 0.00% |
|
| 07-03 | Genfit soars on news of U.S. reimbursement for a product |  |
| 07-03 | Genfit's Liver Disease Blood Test Approved for US Medicare Reimbursement | MT |
Basic data
Market Cap (EUR)
700,339,122
Market Cap (USD)
806,284,967
Net sales (EUR)
71,115,000
Net sales (USD)
81,873,129
Free-Float
86.88 %
Free-Float capitalization (EUR)
608,639,780
Free-Float capitalization (USD)
700,713,539
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | - | - | 806M | |
| -0.80% | +5.16% | -0.70% | +13.00% | 49.37B | |
| -3.95% | +14.70% | +24.15% | +5.15% | 39.14B | |
| +6.22% | +1.81% | +419.17% | +647.45% | 40.85B | |
| -1.57% | -1.44% | +7.38% | +43.06% | 35.81B | |
| +5.56% | +11.70% | +11.64% | +51.50% | 30.5B | |
| -0.39% | -0.63% | - | - | 16.55B | |
| -1.13% | -4.54% | +32.10% | +126.95% | 16.14B | |
| -7.10% | -2.81% | -8.80% | -34.35% | 12.77B | |
| -0.06% | +3.75% | +3.81% | +10.08% | 13.71B | |
| Average | -0.36% | +6.06% | +61.09% | +107.86% | 25.57B | |
| Weighted average by Cap. | +0.22% | +7.02% | +80.20% | +134.94% |
Historical Quotes: GENFIT
| Date | Opening | High | Low | Close | Volume | Change |
|---|
- Stock Market
- Stocks
- GNFT Stock
- Stock
- Quotes GENFIT
Select your edition
All financial news and data tailored to specific country editions
